Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threat
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation, By Diagnostics
6.1 Pet Market
6.2 Spect Market
Chapter 7 Market Segmentation, By Therapeutics
7.1 Brachytherapy
7.2 Beta Emitters
7.3 Alpha Emitters
Chapter 8 Market Segmentation, By Application
8.1 Pet Market
8.2 Spect Market
Chapter 9 Market Segmentation, By Geography
9.1 North America
9.1.1 Introduction
9.1.2 United States
9.1.3 Canada
9.1.4 Mexico
9.1.5 Others
9.2 Europe
9.2.1 Introduction
9.2.2 U.K
9.2.3 Spain
9.2.4 Italy
9.2.5 France
9.2.6 Russia
9.2.7 Others
9.3 Asia-Pacific
9.3.1 Introduction
9.3.2 China
9.3.3 India
9.3.4 Japan
9.3.5 Australia & New Zealand
9.3.6 Others
9.4 South America
9.4.1 Introduction
9.4.2 Brazil
9.4.3 Argentina
9.4.4 Others
9.5 The Middle East & Africa
9.5.1 Introduction
9.5.2 South Africa
9.5.3 Others
Chapter 10 Competitive Landscape
10.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
10.2 Market Share Analysis
10.3 Strategies Adopted By Top Companies
Chapter 11 Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
11.1. GE Healthcare
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Strategic Initiative
11.2. Cardinal Health, Inc.
11.3. Cambridge Isotope Laboratories, Inc.
11.4. Bracco Pharma
11.5. Bracco Imaging S.P.A.
11.6. NTP Radioisotopes SOC Ltd
11.7. Siemens Healthcare
11.8. Triad Isotope
11.9. Iba Group
11.10. Lantheus Medical Imaging
11.11. Mallinckrodt
11.12. Gamma Medica Inc
11.13. Segami Corporation
11.14. Digirad Corporation
11.15. Agfa-Gevaert N.V
Chapter 12 Market Estimates and Forecast
12.1 Market Estimates and Forecast 2018-2024(USD Million)
12.1.1 Market Estimation and Forecast by Diagnostic 2018-2024 (USD Million)
12.1.2 Market Estimation and Forecast by Therapeutics 2018-2024 (USD Million)
12.1.3 Market Estimation and Forecast by Application 2018-2024 (USD Million)
12.1.4 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
Chapter 13 Market Insights
13.1 Insights of Industry Experts
13.2 Analyst Opinion (Market Understanding)
13.3 Investment Opportunities
Chapter 14 Appendix
14.1 List of Tables
14.2 List of Figures
